twins treated for genetic disorder in the womb
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.araka haron
. we value our readers and are committed to growing our community by encouraging you to add to the discussion.
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .español . my profile